United States · FDA National Drug Code directory
Loratadine Allergy Relief
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51660-526_ab379305-5823-49e9-89ca-641c1d37a6f3
- Product NDC
- 51660-526
- Form
- TABLET
- Composition / generic term
- Loratadine
- Labeler
- OHM LABORATORIES INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171101
- Source listing expiry
- 20261231
Source-listed ingredients
- LORATADINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (51660-526-01) · 51660-526-01
- 500 TABLET in 1 BOTTLE (51660-526-05) · 51660-526-05
- 10 TABLET in 1 BLISTER PACK (51660-526-11) · 51660-526-11
- 30 TABLET in 1 BOTTLE (51660-526-30) · 51660-526-30
- 30 TABLET in 1 BLISTER PACK (51660-526-31) · 51660-526-31
- 300 TABLET in 1 BOTTLE (51660-526-53) · 51660-526-53
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →